Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Latest News
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
Media Centre
>
Latest News
Overview
Latest News
Video
Coverage
Latest News
Filter by Year:
2023
2022
2021
2020
13-Dec-2021
Kazia Therapeutics Appoints Karen Krumeich As Chief Financial Officer
3-Dec-2021
Kazia Announces Positive Final Data From Phase Ii Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma
29-Nov-2021
Gbm Agile Opens To Paxalisib In Canada
15-Nov-2021
Kazia Therapeutics Appoints John Friend, Md, As Chief Medical Officer
11-Nov-2021
Pnoc Study In Childhood Brain Cancer Enrols First Patient
10-Nov-2021
Kazia Annual General Meeting Results
4-Nov-2021
Kazia Annual General Meeting Results
29-Oct-2021
Quarterly Activities Report And Appendix 4c
10-Sep-2021
Kazia Therapeutics To Present At Hc Wainwright 23rd Annual Global Investment Conference
2-Sep-2021
Evt801 Phase I Study Receives Full Regulatory Approval
1
2
Next
